Speaker 0: This is Alan Condon with the Becker's CFO and Revenue Cycle podcast. And today, I'm delighted to be joined by John Orsini, executive vice president and CFO of Northwestern Medicine, which is an academic health system headquartered here at Chicago with, I believe, 11 hospitals and more than 5,400 physicians. John, a real pleasure to have you make your your debut appearance on the Becker's podcast with us today. For those of our listeners, our hospital executive audience who might be as well acquainted with yourself or Northwestern, do you mind just giving a little bit of a background into your your role as a CFO? Speaker 1: Sure. Sure. I'm happy to be here. John Orsini, CFO. Been here, ten years. I came to Northwestern as part of the Cadence affiliation. I had been the CFO out there for a few years. And, you know, in my role, pretty typical CFO portfolio, you know, all, financial planning, accounting, internal audit, supply chain, managed care, revenue cycle, debt, you know, all those things. And I work very closely with with our chief operating officer, Craig Johnson. And like you said, we have 11 hospitals across, Chicagoland, and we're about at we'll be just under we're rated about $10,000,000,000 in, net operating revenue. Speaker 0: Fantastic. And, John, the ten years in the CFO seat at Northwestern, I guess, before we dive into some of those questions, significant tenure there with the health system. Any kinda secrets there? What kinda keeps you excited, happy, and engaged, and in the CFO seat for such a long period of time? Speaker 1: Yeah. I mean, we, it was a lot of growth, after I came on board. Tish Health System, Syntegra, Mary and Joy, Palos, all came in and affiliated with us and lot of integration work, a lot of, program development and building. And, you know, we made a wise decision years ago that, we were gonna have one instance of Epic, one instance of, PeopleSoft, our ERP, and, EDW. So, that's just a lot of work and challenging, and our, medical group has grown a lot along the way. I think employment has just increasingly become, you know, kind of the model in The US in terms of health care. And so it's been good in just a lot of great programmatic development, really trying to develop programs that the community wants in those communities. And then we also embarked on a pretty major large ambulatory initiative, and we built, you know, a large multi specialty clinic up at Old Irving Park. We built one out at Oak Brook, and then we have a very large clinic that's gonna be opening in Bronzeville in September that we're pretty, very excited about. And now we're just, you know, trying to figure out what, federal and state reimbursement's gonna look like, going forward in in managing to that. Speaker 0: Right. I can't we think it was kind of jumping into jumping off point for me right now. I think, thanks for kind of sharing the the bit of your background at Northwestern and some of that growth over the last few years, what you're focused on for the moment. In terms of I cannot I can only imagine how much of a challenge a job it must be as a CFO of an academic system at the moment. And you did mention there in terms of really paying close attention what's going on at the federal level, potential Medicaid cuts on the line, and whatnot. I don't assume that's one key trend that you're focused on today, but I I imagine two or three key trends that you're focusing on. Do you wanna start off start off with that one? I assume that's top of mind. And then anything else you're paying close attention to, John? Speaker 1: Sure. I mean, you know, putting all politics aside, whether somebody's on one side of the aisle or the other, you know, the fact of the matter is our the federal government is running, you know, a deficit and has a level of debt that's frankly unsustainable. And I think it's, you know, gonna have to be solved in a variety of ways, whether it's revenue increases and reductions in spending. And I what we believe, is that reimbursement from both the state and federal level has likely peaked in probably in calendar year '24, and we think it's going to flatten out or go down from here. And if it's flattening, it's still a cut because our cost of doing business goes up every year. So, you know, we're preparing, you know, we always have contingency plans in flight. You You know, what we like to say is we always try to have a little x little toothpaste still in the tube. So we know it's gonna Medicaid is probably an area that is likely to be changed. I think the federal government, will probably ask the states to go back to a fifty fifty share for all Medicaid. It's ninety ten on expansion and then make that a state issue. That's challenging for Illinois in that, the current state laws, if it goes below 90, there's a triggering that Illinois would not participate in the expansion, but I think they're working through some changes to that. The other thing I think, site neutrality, three forty b, they're all combinations. I also think the federal government may step back from, you know, the the generous subsidies they provide for the exchanges, which would mean more sell you know, more people that don't have insurance. So it's, you know, it's gonna be challenging. And we're, you know, we're planning for everything and, you know, we'll we'll figure it out. I think we're also hopeful that this won't occur in one fell swoop, that it'll probably be phased over time because some of these changes will be pretty catastrophic for certain segments in health care. And, I I think, you know, the the government is cognizant of that, you know, and the government funds, you know, probably about 50 plus percent of the health care in the country. So what they do will have a profound impact on, you know, on patients', you know, health status. Speaker 0: Mhmm. I I and, John, I'm wondering, in terms of that, the contingency planning, I think, how how are you planning? Given how unpredictable the landscape is at the moment, given how much is going on at the state and the federal level, to your point, a lot of these funding cuts won't be one fell swoop, but there's certainly a lot happening at the moment and and the the potential impact on hospitals, access to care, really across the country is is quite significant. But with that in mind, and again, it's kind of a lot of folks are still in wait and see mode. What does your contingency plan look like kind of a CFO? What are the kind of key areas that you're, focusing on there? Speaker 1: Well, you know, unfortunately, all these options are not good. I mean, they're hard. And but it's the it's the basics. It's labor management. It is looking at all of our service lines and try to become more efficient in some. Are there service lines that we can't afford to do anymore? And that does not mean government. It just means a particular service line. And because of our geography, I mean, maybe we start to consolidate some activity in fewer places, but so the community still has the ability to to receive care, although they might have to drive a little further. You know, supply chain, I think there's you know, it's challenging. There's always a lot of clinical preference items. We've done a lot of work over the years, but there's more things that we can do. So so all those sort of things. You know? Just, and then also, you know, making sure that we're working with our payers. Another thing that's a challenge is, you know, the denials that we're facing, and that will inform us in terms of will we continue to participate in all the products that we we have now. And we need partnerships with the payers, and, you know, we don't need increases in administrative burden and denials. And that's something that that's very challenging. And I'm sure I'm seeing you write up about it, you know, frequently. And, you know, unfortunately, Medicare Advantage, which provides a lot of great benefits to the beneficiaries in terms of eyeglasses and screenings and things, they make it very difficult for health systems to move patients through the continuum. So, generally, the length of stay is longer because it's more challenging to get them into a SNF or home health or rehabilitative services. So when you compare it to traditional Medicare, traditional Medicare, although we're paid the same, it's it's frankly a lot more efficient for us to have patients in Medicare. The length of stays lower, the readmissions are lower, and we don't get into, you know, downcoatings and denials. You know, the the federal government has a very robust audit process with their rack process, and we always fare very well. So, you know, health plans that are just downcoding and saying you overcoat it, I think the challenge we have is, like, well, we're not hearing that from traditional Medicare that has, you know, a a very robust audit process as well. So payer behavior is is top of mind as well. Speaker 0: Right. So I'd like to see if those across the board really to to your point and sound in the alarm on the the alarming rate that we've seen denials in recent years, the administrative challenges that we always hear, reimbursement rates, really have not kept pace with the rate of inflation as well. Not to not to dive too deep into the challenges here, but, I wanted to kind of flip flip the script and talk about the other side of the coin for a second, John, in terms of Northwestern, when you think about the future of the health system, the future of the health care, what are you most excited about? Speaker 1: I think, you know, I think the rate of discovery and knowledge in terms of health care, I think some people would say we're entering the golden age. I think with AI and the ability to do a lot more predictive analysis, I'm excited about how we're starting to think about AI in terms of augmenting clinical care. We're not gonna it's not gonna replace clinical care, but it has the ability to help augment in a very beneficial way. I think, things from a discovery perspective, you know, one thing that we have done at Northwestern, you know, we did the first double lung transplant during COVID. We have a very, very successful solid organ transplant program. And just seeing what these physician scientists are capable of doing and what are doing, it's it's amazing. Another thing is we our lung transplant, they came up with an idea. It's called the dream project. And people that have stage four lung cancer, if a liquid biopsy shows that the cancer is not spread, we've, I think, done 20 or so cases where we basically replaced the lung. We've transplanted a new lung, and then the cancer is gone. And these were folks that were stage four, and were being told that you we're not sure how much more time you're gonna have and you need to get your affairs in order. So it's things like that over and over and over in terms of treatments, and that we're able to do and and just seeing these physicians, it's inspiring. And I think the AI in in really being able to look at, you know, millions of patient files and datasets de identified to to start to understand trends and what works and what doesn't work, I think will, you know, benefit us very well. Speaker 0: Yeah. That's fantastic. I mean, Northwestern really on the forefront of allowing us innovation. That that first double lung transplant during the pandemic as well, certainly a big feather in your your physician, your teams, your health systems cap. I'm curious, John, when you you talked about the golden age of AI there in terms of predictive analysis, automation. I'm curious when you think about from a financial perspective, is there is there a particular area of growth, a particular opportunity that you see maybe as it as it pertains to the revenue cycle or anything there that may could make a significant, financial impact? Speaker 1: I think what we're thinking about for us from a growth perspective is really coronary growth, that high, high end of orthopedics, neuroscience, oncology, you know, transplant cardiovascular. The Blum Cardiovascular Institute has done very well. And I think, really focusing on how do we create efficiency and make it easy for patients to access. But then also on on on the different end, it's total population health management. How do we really take best advantage of, you know, the transitional care management programs and chronic care management programs to keep people, you know, healthy at home. And we're working on a whole care at home, you know, program. We have hospital at home now, and we're doing, you know, more of this remote monitoring and really trying to keep people, you know, more stable. So they're just not, you know, bouncing in and out of the emergency room, which really isn't good for anybody. It's like we we have an obligation to keep those folks as healthy as they can in the in the safest place. You know, going to the emergency room is, it it's challenging for the family, for the patient. They're it's a chaotic environment, and, that's an exciting thing using technology. And, also, with our EDW, we're able to our Bloom Cardiovascular folks have done a lot of work on predicting who is at most risk for readmission and then making sure that we, you know, develop that wraparound care for those folks, so that so they're not coming back and and not having that readmission. Speaker 0: Yeah. It's fascinating. We're gonna hear you breakdown. In layman's terms, for folks like me, there's kinda those key areas of growth, the opportunities that you see from the core areas Northwestern is working on, hospital at home, care at home, a lot of ambulatory growth you said earlier in the conversation at your system. Where when you look ahead the next twelve months or so, John, what are the kind of core areas that you're looking to grow, Northwestern? Speaker 1: I mean, we are are really looking to grow probably, continued growth in oncology. We're really trying to grow our neuroscience. We've had some recruits. We have some folks coming in, on the neuroscience side. Cardiovascular has just been growing. We've done, you know, doctor Doug Johnston who, you know, was handed the baton from doctor Pat McCarthy, who's still very involved, has really done some recruiting and they they've grown quite a bit. So I think those are the the big areas. Hospital at home, although very small scale, we're very optimistic that we can we're we view that as our twelfth hospital, and we think there's an opportunity at at some point to, you know we we look to Mass General with the with the size of their hospital at home, and, you know, it's not inconceivable that down the road, we could have a hundred patients a day in hospital at home, which takes a lot of pressure off of our facilities, which are all pretty full. Mhmm. Speaker 0: So on that note, I think, I've heard a ton of CFOs like yourself recently talk about the big opportunity for growth in the hospital at home space. You just said there are 11 hospitals at Northwestern. You've used your your 12 hospitals, the hospital at home program. But kind of side stepping from that, academic health systems across the country, we've seen a a string of acquisitions of community hospitals, when I think about, Penn Medicine, for example, Duke Health, Emory Health in Georgia. Some of these systems come to mind. But when Northwestern is thinking about growth, is acquiring hospitals on the agenda? We we also just saw the big eight hospital acquisitions which comes from Ascension to Prime Healthcare in Illinois, close market as well. Is the is m and a something that's on the agenda or, assessing other options for future? Speaker 1: I mean, we we're always willing to talk to everybody. I think if we did some expansion, it might be more on the ambulatory side. I think because of the FTC, it would be challenging for us to, you know, acquire more hospitals in in the Chicagoland. And if they also have to fit, you know, they have to fit with us culturally. They have to fit with us from a, you know, a fit and finish perspective. We're very cognizant of it's tough to take on a new, you know, facility if it's gonna require 4 to $500,000,000 in investment because we're investing you know, I'm very proud to say that Northwestern, we invest about $500,000,000 a year in capital. And, you know, that's something that people don't talk about. I think we it's a gigantic community benefit from a CFO perspective. It's equipment. It's buildings. We're we're hiring people to build it, maintain it, and then perform that clinical activity. So, activity. So, you know, we are probably more growing from a, same store perspective, but we never say no to anything. The one thing we keep our eye on is also, is, you know, the large multistates, it's I find that to be challenging only from the standpoint that from an information system perspective, unfortunately, you don't get scale. It's the same amount per license. So and from an insurance perspective, because they're all state managed, it's hard to get, you know, any changes in language or or you can do it, but it takes time because you have to line up all the contracts across the states. So I don't I think it's probably less likely than more likely that we would become a, you know, multistate system unless something really compelling came along because we we just don't wanna grow for growth's sake. It can be a distraction, and, it you know, we we wanna keep our eye on the one point four million active patients that we already have that we're, you know, obligated and we're, you know, trying to try and do our best to take care of the best we can. Speaker 0: Right. Yeah. So it sounds like certainly looking to really grow some of those fantastic service lines that you mentioned, neuroscience, orthopedics. Potentially, if an opportunity comes along, you might explore it, but maybe outpatient or ambulatory m and a opportunities might be something more more on the agenda for Northwestern. Right? Speaker 1: Because, I mean, if you put in perspective, we've, you know, added, 10 hospitals over the last seven or eight years. So, I mean, we we've done a lot of that growth that you're seeing happen now with other health systems. We're just at a different point in our journey. Speaker 0: Yeah. Absolutely. John, listen, it's been an absolute pleasure. Really, really, fantastic to have you, Joy. And make your debut appearance on the Becker's podcast with us today, I've really, really enjoyed getting to know you a little bit more here, a little bit more about some of those some of those growth opportunities, so how you're tackling some of the challenges of today at Northwestern. Really, really a pleasure. Thank you so much for taking the time, and I look forward to connecting with you again. You're very and I'm happy to Speaker 1: do it anytime. You're very welcome, and and thank you guys for all you do for the industry.